Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
LPATH
(NQ:
LPTN
)
4.570
USD
UNCHANGED
Official Closing Price
/ Updated:
4:00 PM EDT, Jun 18, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
4.640
Bid (Size)
4.500 (700)
Ask (Size)
4.740 (100)
Prev. Close
4.570
Today's Range
4.570 - 4.750
52wk Range
4.130 - 7.010
Shares Outstanding
13,128,250
Dividend Yield
N/A
Top News
More News
Lpath Granted Key U.S. Patent Related to Ocular Drug Program, iSONEP
May 30, 2013
Patent Provides Coverage for Lpath's Anti-S1P Antibody in the Treatment of a Wide Variety of Ocular Disorders, Including Wet AMD
Read More
from
GlobeNewswire News Releases
Lpath Initiates Dosing in First Proof-of-Concept Trial of Anti-Cancer Drug, ASONEP
May 23, 2013
ASONEP Trial to Study Effects of Lpath's Anti-S1P Antibody in Subjects With Renal Cell Carcinoma
Read More
from
GlobeNewswire News Releases
More News
Read More
Lpath Adds Two Key Members to its Executive Team
April 16, 2013
from
GlobeNewswire News Releases
Moves in Smaller Health Care Stocks (ANAC, HALO, PBYI, QCOR)
March 23, 2013
category
SGEN
,
Puma Biotechnology
,
OPK
, and 24 more.
from
Latest Articles from Benzinga.com
Lpath Says Wins Key European, US Patents Related to Asonep
March 22, 2013
category
Benzinga
,
News
,
LPTN
from
Latest Articles from Benzinga.com
Lpath Granted Key European and U.S. Patents Related to Anti-Cancer Drug Program, ASONEP
March 22, 2013
from
Marketwired News Releases
Lpath to Present at ROTH Capital Partners 25th Annual Growth Stock Conference on March 19, 2013
March 12, 2013
from
Marketwired News Releases
Lpath Signs Collaboration and License Agreement With Provista Diagnostics to Develop Cancer Diagnostics
March 06, 2013
from
Marketwired News Releases
Lpath to Present Data at Arrowhead's 3rd Annual Traumatic Brain Injury Conference on March 7, 2013
February 25, 2013
from
Marketwired News Releases
Lpath Promotes Leigh Hsu, Ph.D., to Vice President of Corporate Development
February 13, 2013
from
Marketwired News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here